Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19837
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMeneghello, G.-
dc.contributor.authorVerheyen, A.-
dc.contributor.authorVan Ingen, M.-
dc.contributor.authorKUIJLAARS, Jacobine-
dc.contributor.authorTuefferd, M.-
dc.contributor.authorVan den Wyngaert, I.-
dc.contributor.authorNuydens, R.-
dc.date.accessioned2015-11-27T09:12:10Z-
dc.date.available2015-11-27T09:12:10Z-
dc.date.issued2015-
dc.identifier.citationNEUROSCIENCE, 301, p. 204-212-
dc.identifier.issn0306-4522-
dc.identifier.urihttp://hdl.handle.net/1942/19837-
dc.description.abstractNeurodegenerative diseases are difficult to study due to unavailability of human neurons. Cell culture systems and primary rodent cultures have shown to be indispensable to clarify disease mechanisms and provide insights into gene functions. Nevertheless, it is hard to translate new findings into new medicines. The discovery of human induced pluripotent stem cells (iPSC) might partially overcome this problem. Commercially available human iPSC-derived neurons, when thoroughly characterized and suitable for viral transduction, might represent a faster model for drugs screening than the time-consuming derivation and differentiation of iPSC from patient samples. In this study we show that iCell (R) neurons are primarily immature GABAergic neurons within the tested time frame. Addition of C6 glioma conditioned medium improved the bursting frequency of cells without further maturation or evidence for glutamatergic responses. Furthermore, cells were suitable for lentiviral transduction within the tested time frame. Altogether, iCell (R) neurons might be useful to model neurodegenerative diseases in which young GABAergic subtypes are affected. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.-
dc.description.sponsorshipInstitute for the Promotion of Innovation by Science and Technology in Flanders [IWT 120511]-
dc.language.isoen-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.rights© 2015 IBRO. Published by Elsevier Ltd. All rights reserved.-
dc.subject.otherdisease modeling; neurodegeneration; hiPSC; GABAergic neuron-
dc.subject.otherdisease modeling; neurodegeneration; hiPSC; GABAergic neuron-
dc.titleEvaluation of established human IPSC-derived neurons to model neurodegenerative diseases-
dc.typeJournal Contribution-
dc.identifier.epage212-
dc.identifier.spage204-
dc.identifier.volume301-
local.format.pages9-
local.bibliographicCitation.jcatA1-
dc.description.notes[Meneghello, G.; Verheyen, A.; Van Ingen, M.; Tuefferd, M.; Van den Wyngaert, I.; Nuydens, R.] Janssen Pharmaceut NV, Div A, Janssen Res & Dev, B-2340 Beerse, Belgium. [Kuijlaars, J.] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium.-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.neuroscience.2015.05.071-
dc.identifier.isi000357877800018-
item.validationecoom 2016-
item.contributorMeneghello, G.-
item.contributorVerheyen, A.-
item.contributorVan Ingen, M.-
item.contributorKUIJLAARS, Jacobine-
item.contributorTuefferd, M.-
item.contributorVan den Wyngaert, I.-
item.contributorNuydens, R.-
item.accessRightsRestricted Access-
item.fullcitationMeneghello, G.; Verheyen, A.; Van Ingen, M.; KUIJLAARS, Jacobine; Tuefferd, M.; Van den Wyngaert, I. & Nuydens, R. (2015) Evaluation of established human IPSC-derived neurons to model neurodegenerative diseases. In: NEUROSCIENCE, 301, p. 204-212.-
item.fulltextWith Fulltext-
crisitem.journal.issn0306-4522-
crisitem.journal.eissn1873-7544-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1-s2.0-S0306452215005229-main.pdf
  Restricted Access
2.79 MBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

9
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

14
checked on Apr 30, 2024

Page view(s)

86
checked on Apr 17, 2023

Download(s)

58
checked on Apr 17, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.